Insulet, headquartered in Acton, Massachusetts, develops and markets insulin infusion systems, including the Omnipod 5 Automated Insulin Delivery System, for insulin-dependent diabetes. The company employs 3,000 staff and went public in 2007.
Prem Singh sold 2,327 shares of PODD on 13 June at $300.05 per share, worth a total of $698K. They now own 4,143 PODD shares, or a 36% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
